Evidence map›Paper›PMID 42379786›Full record

ArticleIn vivo (Athens, Greece)

Utility of a Simplified Irradiator for Photosensitivity Testing in Head and Neck Photoimmunotherapy.

Tatsuya Yamakura, Isaku Okamoto, Takuro Okada, Kunihiko Tokashiki, Kiyoaki Tsukahara

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tatsuya YamakuraDepartment of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan yamakura.tatsuya.2r@tokyo-med.ac.jp.
Isaku OkamotoDepartment of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
Takuro OkadaDepartment of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
Kunihiko TokashikiDepartment of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
Kiyoaki TsukaharaDepartment of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimHead and neck photoimmunotherapy (HN-PIT) using cetuximab sarotalocan sodium requires post-treatment assessment for photosensitivity, but tests using direct sunlight are affected by weather and lack standardization. This study evaluated a simplified artificial irradiator for more consistent light irradiation testing. PATIENTS AND

methodsThis single-center retrospective study analyzed 16 HN-PIT treatments in 8 patients with unresectable locally advanced or recurrent head and neck cancer. On days 6-7 post-treatment, patients underwent both direct sunlight exposure and a simple irradiation test using a FLASH-PAK projector equipped with an R-60 filter to evaluate reactions around the clinically relevant 690 nm wavelength. Erythema and edema were assessed on the day of the test and 1 month later.

resultsNo photosensitivity reactions occurred with either method, nor were delayed reactions observed.

conclusionThe simplified irradiator allows standardized, weather-independent photosensitivity testing after HN-PIT, although further studies are needed to confirm sensitivity and long-term reliability.

Indexed as

Head and Neck NeoplasmsImmunotherapyPhotosensitivity DisordersPhototherapyAgedCetuximabFemaleHumansMaleMiddle AgedRetrospective StudiesSunlightCetuximabAlluminox treatment of head and neck cancercetuximab sarotalocanphotoimmunotherapyphotosensitivityPITskin irradiation test

Identifiers

PMID42379786
PMCPMC13322094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.